(INCY:Consolidated Issue Listed on NASDAQ Global Select )
Reid M. Huber Ph.D.
Chief Scientific Officer and Executive Vice President, Incyte Corporation
|Age||Total Calculated Compensation||This person is connected to 10 board members in 1 different organizations across 2 different industries.|
See Board Relationships
As of Fiscal Year 2014
Dr. Reid M. Huber, Ph.D. has been Chief Scientific Officer and Executive Vice President of Incyte Corporation since May 2014. Dr. Huber leads drug discovery research primarily in the area of hematology/oncology. He served as Senior Vice President of Discovery Biology at Incyte Corporation. He was a founding member of the team that started drug discovery at Incyte Corporation in 2002. Dr. Huber joined Incyte in January 2002 as an Associate Director of Applied Technology. ...
1801 Augustine Cut-OffPhone: 302-498-6700
Wilmington, Delaware 19803
Board Members Memberships*
Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
Washington University, St. Louis
Murray State University
|Richard F. Pops||Chairman of the Board and Chief Executive Officer|
|Harvey J. Berger M.D.||Principal Founder, Chairman, Chief Executive Officer, President and Chairman of Executive Committee|
Ariad Pharmaceuticals Inc.
|Jean-Jacques Bienaime MBA||Chief Executive Officer and Director|
BioMarin Pharmaceutical Inc.
|Jeffrey M. Leiden M.D., Ph.D.||Chairman, Chief Executive Officer and President|
Vertex Pharmaceuticals Incorporated
|Bruce C. Cozadd||Co-Founder, Executive Chairman and Chief Executive Officer|
Jazz Pharmaceuticals Public Limited Company
|$830.0K||Compensation as of Fiscal Year 2014.|